Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
Suleiman Massarweh(University of Kentucky), Rachel Schiff(Baylor College of Medicine), Shixia Huang(Southwest University), Heidi L. Weiss(Pancreatic Cancer Action Network), Mothaffar F. Rimawi(Baylor College of Medicine), Anna Tsimelzon(Pancreatic Cancer Action Network), Lanfang Qin(Pancreatic Cancer Action Network), Chad J. Creighton(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine)
Cited by 494
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k